Japan Hydrogel-based Drug Delivery System Market Size & Outlook

The hydrogel-based drug delivery system market in Japan is expected to reach a projected revenue of US$ 343.0 million by 2028. A compound annual growth rate of 7% is expected of Japan hydrogel-based drug delivery system market from 2022 to 2028.
Revenue, 2021 (US$M)
$213.1
Forecast, 2028 (US$M)
$343.0
CAGR, 2022 - 2028
7%
Report Coverage
Japan

Japan hydrogel-based drug delivery system market, 2016-2028 (US$M)

Japan

Japan hydrogel-based drug delivery system market highlights

  • The Japan hydrogel-based drug delivery system market generated a revenue of USD 213.1 million in 2021 and is expected to reach USD 343.0 million by 2028.
  • The Japan market is expected to grow at a CAGR of 7% from 2022 to 2028.
  • In terms of segment, synthetic was the largest revenue generating polymer origin in 2021.
  • Hybrid is the most lucrative polymer origin segment registering the fastest growth during the forecast period.


Hydrogel-based drug delivery system market data book summary

Market revenue in 2021USD 213.1 million
Market revenue in 2028USD 343.0 million
Growth rate7% (CAGR from 2021 to 2028)
Largest segmentSynthetic
Fastest growing segmentHybrid
Historical data2016 - 2020
Base year2021
Forecast period2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationNatural, Synthetic, Hybrid
Key market players worldwideGalderma Group AG Registered Shares, Johnson & Johnson, Bausch & Lomb Corp, Medtronic PLC, Ocular Therapeutix Inc, Fresenius SE & Co KGaA, Blairex Laboratories, Ferring, Endo Pharmaceuticals, TOLMAR


Other key industry trends

  • In terms of revenue, Japan accounted for 3.3% of the global hydrogel-based drug delivery system market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Asia Pacific, China hydrogel-based drug delivery system market is projected to lead the regional market in terms of revenue in 2028.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 477.1 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Hydrogel-based Drug Delivery System Market Companies

Name Profile # Employees HQ Website

Japan hydrogel-based drug delivery system market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hydrogel-based drug delivery system market will help companies and investors design strategic landscapes.


Synthetic was the largest segment with a revenue share of 56.87% in 2021. Horizon Databook has segmented the Japan hydrogel-based drug delivery system market based on natural, synthetic, hybrid covering the revenue growth of each sub-segment from 2016 to 2028.


Reasons to subscribe to Japan hydrogel-based drug delivery system market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Japan hydrogel-based drug delivery system market databook

  • Our clientele includes a mix of hydrogel-based drug delivery system market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Japan hydrogel-based drug delivery system market , including forecasts for subscribers. This country databook contains high-level insights into Japan hydrogel-based drug delivery system market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Japan hydrogel based drug delivery system market size, by polymer origin, 2016-2028 (US$M)

Japan Hydrogel-based Drug Delivery System Market Outlook Share, 2021 & 2028 (US$M)

Japan hydrogel based drug delivery system market size, by polymer origin, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more